If cancer is a disease of overabundance, where cells divide without restraint and tumors grow despite the body's best interests, then degenerative diseases are disorders of deprivation. When ...

Neurological disorders affect the function of the nervous system. Common pediatric neurological disorders include ADHD, autism spectrum disorder, epilepsy, and cerebral palsy. Neurological disorders ...

Pathologic changes of the X-chromosome gene for dystrophin give rise to Duchenne muscular dystrophy (DMD), and dystrophin -- which minimizes muscle fiber loss due to sarcolemma contraction damage when ...

Neurological diseases affect the nervous system, including the brain, spinal cord, and peripheral nerves that carry signals throughout your body. These conditions can disrupt movement, thinking, mood, ...

Congenital muscular dystrophies (CMDs) comprise a heterogeneous group of inherited disorders primarily affecting muscle integrity and function, often with accompanying brain and ocular abnormalities.

When it comes to muscular diseases, most of us have heard of especially common ones like muscular dystrophy and Lou Gehrig's disease. But one of the rarest muscular disorders is also one of the most ...

Muscular dystrophy (MD) is a group of genetic diseases that cause your muscles to progressively weaken and degenerate. There are several types of MD, each with its own symptoms, but they all involve ...

Duchenne muscular dystrophy is the most common early onset form of muscular dystrophy; many boys become wheelchair bound in their teens and die in their twenties. People with limb girdle muscular ...

—Navigating the intricacies of health insurance policies to get coverage for needed medical care is often a huge burden for patients and caregivers battling a rare disease. A new study opens a window ...

In India, rare diseases are not so rare. It is estimated that around 70 million Indians live with one of more than 7,000 rare ...

The U.S. Food and Drug Administration has approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in patients 2 years and older with confirmed mutation in ...